Objectives: Uroplakin (UP) II and UPIII are highly specific immunohistochemical markers for urothelial differentiation. Here we studied the sensitivity of UPII and UPIII in conventional and variant urothelial carcinomas (UCs). Methods: Immunohistochemical staining for UPII and UPIII was performed on tissue microarray slides, including 105 conventional bladder UCs (BUCs), 90 upper urinary tract UCs (UUTUCs), and 47 micropapillary, 16 plasmacytoid, 22 small cell carcinoma, and 41 sarcomatoid UC variants. Results: UPII expression was significantly higher than UPIII expression in conventional BUC (44 % vs 17%, P <.001) and UUTUC (67 % vs 46%, P =.045). UPIII expression was significantly higher in UUTUC than in BUC (P <.001). In UC variant...
Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of urothelial carcinomas (UCs)...
We recently defined molecular subtypes of urothelial carcinomas according to whole genome gene expre...
Urothelial carcinoma (UC) comprises a heterogeneous group of epithelial neoplasms with diverse biolo...
Background: Urothelial carcinoma (UC) variants can be difficult to differentiate from carcinoma meta...
OBJECTIVE: To discern any differences in the distribution of uroplakin expression on neoplastic and ...
Background: Uroplakins have been widely investigated as potential markers in patients with bladder c...
Background. Uroplakins are glycoproteins investigated as potential markers of urothelial carcinoma. ...
Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTC...
OBJECTIVES Current methods for reliable detection of bladder cancer have some limitations. Finding b...
Background. Urothelial carcinoma is the most common type of bladder cancer (BC). It makes up more th...
SummaryRecently developed antibodies against uroplakin II and ΔNp63 (p40) show utility in diagnosing...
OBJECTIVES: Whole genome expression profiles allow the stratification of bladder urothelial carcinom...
<div><p>Introduction</p><p>Prior studies have shown genetic similarities between upper tract and bla...
<p>A: A panel of commonly used urothelial cell lines was screened via traditional RT-PCR for the pre...
Abstract Several immunohistochemical markers have been used to define the differentiation pattern o...
Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of urothelial carcinomas (UCs)...
We recently defined molecular subtypes of urothelial carcinomas according to whole genome gene expre...
Urothelial carcinoma (UC) comprises a heterogeneous group of epithelial neoplasms with diverse biolo...
Background: Urothelial carcinoma (UC) variants can be difficult to differentiate from carcinoma meta...
OBJECTIVE: To discern any differences in the distribution of uroplakin expression on neoplastic and ...
Background: Uroplakins have been widely investigated as potential markers in patients with bladder c...
Background. Uroplakins are glycoproteins investigated as potential markers of urothelial carcinoma. ...
Our purpose was to determine the clinical relevance of the detection of circulating tumor cells (CTC...
OBJECTIVES Current methods for reliable detection of bladder cancer have some limitations. Finding b...
Background. Urothelial carcinoma is the most common type of bladder cancer (BC). It makes up more th...
SummaryRecently developed antibodies against uroplakin II and ΔNp63 (p40) show utility in diagnosing...
OBJECTIVES: Whole genome expression profiles allow the stratification of bladder urothelial carcinom...
<div><p>Introduction</p><p>Prior studies have shown genetic similarities between upper tract and bla...
<p>A: A panel of commonly used urothelial cell lines was screened via traditional RT-PCR for the pre...
Abstract Several immunohistochemical markers have been used to define the differentiation pattern o...
Introduction: Upper tract urothelial carcinoma (UTUC) accounts for 5% of urothelial carcinomas (UCs)...
We recently defined molecular subtypes of urothelial carcinomas according to whole genome gene expre...
Urothelial carcinoma (UC) comprises a heterogeneous group of epithelial neoplasms with diverse biolo...